Summary

Report Overview
Hematological malignancy is a major disease that seriously endangers human health. With the invention and application of polymerase chain reaction, immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization, its overall diagnostic level has been significantly improved.Increasing prevalence of hematological malignancies, emerging new technologies and methods for testing, patient preference for testing treatments, and increasing regulation across the healthcare industry are the key factors driving the growth of hematological malignancies testing market revenue.

The global Hematologic Malignancies Detection market size was estimated at USD 2897.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 14.60% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Hematologic Malignancies Detection market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Hematologic Malignancies Detection market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hematologic Malignancies Detection market.
Global Hematologic Malignancies Detection Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
ArcherDx
Bio-Rad Laboratories
sysmex
Invitae
NeoGenomics Laboratories
Abbott Laboratories
Cancer Genetics
Adaptive Biotechnologies Corporation
Asuragen
Invivoscribe
Nanjing Shihejiyin Technology
Annaroad Gene Technology
BGI Genomics

Market Segmentation (by Type)
Polymerase Chain Reaction
Immunochemistry
Next Generation Sequencing
Fluorescence in Situ Hybridization
Others

Market Segmentation (by Application)
Multiple Myeloma
Myelodysplastic Syndrome
Leukemia
Myeloproliferative Neoplasms
Lymphoma
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hematologic Malignancies Detection Market
Overview of the regional outlook of the Hematologic Malignancies Detection Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hematologic Malignancies Detection Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Hematologic Malignancies Detection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

ページTOPに戻る

Table of Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hematologic Malignancies Detection
1.2 Key Market Segments
1.2.1 Hematologic Malignancies Detection Segment by Type
1.2.2 Hematologic Malignancies Detection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hematologic Malignancies Detection Market Overview
2.1 Global Market Overview
2.1.1 Global Hematologic Malignancies Detection Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Hematologic Malignancies Detection Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hematologic Malignancies Detection Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Hematologic Malignancies Detection Product Life Cycle
3.3 Global Hematologic Malignancies Detection Sales by Manufacturers (2020-2025)
3.4 Global Hematologic Malignancies Detection Revenue Market Share by Manufacturers (2020-2025)
3.5 Hematologic Malignancies Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hematologic Malignancies Detection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Hematologic Malignancies Detection Market Competitive Situation and Trends
3.8.1 Hematologic Malignancies Detection Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hematologic Malignancies Detection Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Hematologic Malignancies Detection Industry Chain Analysis
4.1 Hematologic Malignancies Detection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hematologic Malignancies Detection Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hematologic Malignancies Detection Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hematologic Malignancies Detection Market
5.7 ESG Ratings of Leading Companies
6 Hematologic Malignancies Detection Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hematologic Malignancies Detection Sales Market Share by Type (2020-2025)
6.3 Global Hematologic Malignancies Detection Market Size by Type (2020-2025)
6.4 Global Hematologic Malignancies Detection Price by Type (2020-2025)
7 Hematologic Malignancies Detection Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hematologic Malignancies Detection Market Sales by Application (2020-2025)
7.3 Global Hematologic Malignancies Detection Market Size (M USD) by Application (2020-2025)
7.4 Global Hematologic Malignancies Detection Sales Growth Rate by Application (2020-2025)
8 Hematologic Malignancies Detection Market Sales by Region
8.1 Global Hematologic Malignancies Detection Sales by Region
8.1.1 Global Hematologic Malignancies Detection Sales by Region
8.1.2 Global Hematologic Malignancies Detection Sales Market Share by Region
8.2 Global Hematologic Malignancies Detection Market Size by Region
8.2.1 Global Hematologic Malignancies Detection Market Size by Region
8.2.2 Global Hematologic Malignancies Detection Market Size by Region
8.3 North America
8.3.1 North America Hematologic Malignancies Detection Sales by Country
8.3.2 North America Hematologic Malignancies Detection Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hematologic Malignancies Detection Sales by Country
8.4.2 Europe Hematologic Malignancies Detection Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hematologic Malignancies Detection Sales by Region
8.5.2 Asia Pacific Hematologic Malignancies Detection Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hematologic Malignancies Detection Sales by Country
8.6.2 South America Hematologic Malignancies Detection Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hematologic Malignancies Detection Sales by Region
8.7.2 Middle East and Africa Hematologic Malignancies Detection Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Hematologic Malignancies Detection Market Production by Region
9.1 Global Production of Hematologic Malignancies Detection by Region(2020-2025)
9.2 Global Hematologic Malignancies Detection Revenue Market Share by Region (2020-2025)
9.3 Global Hematologic Malignancies Detection Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hematologic Malignancies Detection Production
9.4.1 North America Hematologic Malignancies Detection Production Growth Rate (2020-2025)
9.4.2 North America Hematologic Malignancies Detection Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hematologic Malignancies Detection Production
9.5.1 Europe Hematologic Malignancies Detection Production Growth Rate (2020-2025)
9.5.2 Europe Hematologic Malignancies Detection Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hematologic Malignancies Detection Production (2020-2025)
9.6.1 Japan Hematologic Malignancies Detection Production Growth Rate (2020-2025)
9.6.2 Japan Hematologic Malignancies Detection Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hematologic Malignancies Detection Production (2020-2025)
9.7.1 China Hematologic Malignancies Detection Production Growth Rate (2020-2025)
9.7.2 China Hematologic Malignancies Detection Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 ArcherDx
10.1.1 ArcherDx Basic Information
10.1.2 ArcherDx Hematologic Malignancies Detection Product Overview
10.1.3 ArcherDx Hematologic Malignancies Detection Product Market Performance
10.1.4 ArcherDx Business Overview
10.1.5 ArcherDx SWOT Analysis
10.1.6 ArcherDx Recent Developments
10.2 Bio-Rad Laboratories
10.2.1 Bio-Rad Laboratories Basic Information
10.2.2 Bio-Rad Laboratories Hematologic Malignancies Detection Product Overview
10.2.3 Bio-Rad Laboratories Hematologic Malignancies Detection Product Market Performance
10.2.4 Bio-Rad Laboratories Business Overview
10.2.5 Bio-Rad Laboratories SWOT Analysis
10.2.6 Bio-Rad Laboratories Recent Developments
10.3 sysmex
10.3.1 sysmex Basic Information
10.3.2 sysmex Hematologic Malignancies Detection Product Overview
10.3.3 sysmex Hematologic Malignancies Detection Product Market Performance
10.3.4 sysmex Business Overview
10.3.5 sysmex SWOT Analysis
10.3.6 sysmex Recent Developments
10.4 Invitae
10.4.1 Invitae Basic Information
10.4.2 Invitae Hematologic Malignancies Detection Product Overview
10.4.3 Invitae Hematologic Malignancies Detection Product Market Performance
10.4.4 Invitae Business Overview
10.4.5 Invitae Recent Developments
10.5 NeoGenomics Laboratories
10.5.1 NeoGenomics Laboratories Basic Information
10.5.2 NeoGenomics Laboratories Hematologic Malignancies Detection Product Overview
10.5.3 NeoGenomics Laboratories Hematologic Malignancies Detection Product Market Performance
10.5.4 NeoGenomics Laboratories Business Overview
10.5.5 NeoGenomics Laboratories Recent Developments
10.6 Abbott Laboratories
10.6.1 Abbott Laboratories Basic Information
10.6.2 Abbott Laboratories Hematologic Malignancies Detection Product Overview
10.6.3 Abbott Laboratories Hematologic Malignancies Detection Product Market Performance
10.6.4 Abbott Laboratories Business Overview
10.6.5 Abbott Laboratories Recent Developments
10.7 Cancer Genetics
10.7.1 Cancer Genetics Basic Information
10.7.2 Cancer Genetics Hematologic Malignancies Detection Product Overview
10.7.3 Cancer Genetics Hematologic Malignancies Detection Product Market Performance
10.7.4 Cancer Genetics Business Overview
10.7.5 Cancer Genetics Recent Developments
10.8 Adaptive Biotechnologies Corporation
10.8.1 Adaptive Biotechnologies Corporation Basic Information
10.8.2 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product Overview
10.8.3 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product Market Performance
10.8.4 Adaptive Biotechnologies Corporation Business Overview
10.8.5 Adaptive Biotechnologies Corporation Recent Developments
10.9 Asuragen
10.9.1 Asuragen Basic Information
10.9.2 Asuragen Hematologic Malignancies Detection Product Overview
10.9.3 Asuragen Hematologic Malignancies Detection Product Market Performance
10.9.4 Asuragen Business Overview
10.9.5 Asuragen Recent Developments
10.10 Invivoscribe
10.10.1 Invivoscribe Basic Information
10.10.2 Invivoscribe Hematologic Malignancies Detection Product Overview
10.10.3 Invivoscribe Hematologic Malignancies Detection Product Market Performance
10.10.4 Invivoscribe Business Overview
10.10.5 Invivoscribe Recent Developments
10.11 Nanjing Shihejiyin Technology
10.11.1 Nanjing Shihejiyin Technology Basic Information
10.11.2 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product Overview
10.11.3 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product Market Performance
10.11.4 Nanjing Shihejiyin Technology Business Overview
10.11.5 Nanjing Shihejiyin Technology Recent Developments
10.12 Annaroad Gene Technology
10.12.1 Annaroad Gene Technology Basic Information
10.12.2 Annaroad Gene Technology Hematologic Malignancies Detection Product Overview
10.12.3 Annaroad Gene Technology Hematologic Malignancies Detection Product Market Performance
10.12.4 Annaroad Gene Technology Business Overview
10.12.5 Annaroad Gene Technology Recent Developments
10.13 BGI Genomics
10.13.1 BGI Genomics Basic Information
10.13.2 BGI Genomics Hematologic Malignancies Detection Product Overview
10.13.3 BGI Genomics Hematologic Malignancies Detection Product Market Performance
10.13.4 BGI Genomics Business Overview
10.13.5 BGI Genomics Recent Developments
11 Hematologic Malignancies Detection Market Forecast by Region
11.1 Global Hematologic Malignancies Detection Market Size Forecast
11.2 Global Hematologic Malignancies Detection Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hematologic Malignancies Detection Market Size Forecast by Country
11.2.3 Asia Pacific Hematologic Malignancies Detection Market Size Forecast by Region
11.2.4 South America Hematologic Malignancies Detection Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hematologic Malignancies Detection by Country
12 Forecast Market by Type and by Application (2026-2035)
12.1 Global Hematologic Malignancies Detection Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Hematologic Malignancies Detection by Type (2026-2035)
12.1.2 Global Hematologic Malignancies Detection Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Hematologic Malignancies Detection by Type (2026-2035)
12.2 Global Hematologic Malignancies Detection Market Forecast by Application (2026-2035)
12.2.1 Global Hematologic Malignancies Detection Sales (K Units) Forecast by Application
12.2.2 Global Hematologic Malignancies Detection Market Size (M USD) Forecast by Application (2026-2035)
13 Conclusion and Key Findings